Top Stories
Top Stories
Market Insider

Early movers: DD, MMM, VZ, UTX, SBUX, BUD, GILD, BA & more

Stocks to Watch: July 26, 2016

Check out which companies are making headlines before the bell:

DuPont — DuPont earned an adjusted $1.24 per share for the second quarter, 14 cents a share above estimates. Revenue was also above forecasts and the chemical maker also raised its full-year forecast. DuPont had stronger sales in agriculture and other areas, as well as expanded profit margins.

3M — 3M earned $2.08 per share for the second quarter, beating estimates by one cent a share. Revenue came in shy of Street forecasts, and the company lowered its sales growth guidance for 2016.

Caterpillar — The heavy equipment maker beat estimates by 13 cents a share, with quarterly profit of $1.09 per share. Revenue beat forecasts, as well. However, it continues to feel the impact of a decline in the mining industry.

Verizon — The telecommunications giant beat estimates by two cents a share, with adjusted quarterly profit of 94 cents per share. Revenue missed forecasts. Verizon said its results were hurt by a seven-week workers strike.

United Technologies — The industrial conglomerate reported adjusted quarterly profit of $1.82 per share, 14 cents a share above estimates. Revenue also beat forecasts and United Technologies raised its full-year forecast, as well.

Under Armour — The athletic apparel maker matched estimates with profit of one cent per share, and revenue was essentially in line, as well. Under Armour's bottom line showed a 28 percent improvement from a year earlier on greater demand for apparel and basketball shoes.

Starbucks — The coffee chain's stock was added to the "Americas Conviction List" at Goldman Sachs, which said it sees Starbucks comparable-store sales re-accelerating into the fiscal fourth quarter.

Eli Lilly — The drugmaker's earnings matched estimates at 86 cents per share, with revenue above forecasts. Lilly's results were helped by demand for cancer and diabetes treatments.

Gilead Sciences — The drugmaker reported adjusted quarterly profit of $3.08 per share for its latest quarter, beating estimates by six cents a share. Revenue was essentially in line, but investors may focus on Gilead's lower full-year sales outlook. The company pointed to slower-than-expected sales of its hepatitis C drugs.

Anheuser-Busch InBev — The company raised its offer for rival beer brewer SABMiller, in a bid to relieve concerns related to the falling value of the British pound. The offer is now 2.2 percent higher and also increases the cash portion of the deal.

Las Vegas Sands — Las Vegas Sands missed estimates by four cents a share, with adjusted quarterly profit of 52 cents per share. The casino operator's revenue also missed forecasts. Las Vegas Sands was hurt by continuing declines in its Macau operations.

Texas Instruments — Texas Instruments came in four cents a share ahead of Street forecasts, with quarterly profit of 76 cents per share. The chipmaker's revenue also exceeded estimates. The company saw particular strength in its automotive and communications chip segments, among others.

Celgene — Celgene said its Revlimid drug did not extend survival rates in a trial involving a type of blood cancer, and that the drugmaker would not seek approval for the drug for that use.

Goldman Sachs — Goldman will be the subject of an enforcement action by the Federal Reserve, according to The New York Times. The case relates to a leak of confidential information, and will reportedly include a penalty of less than $50 million.

BP — BP reported lower-than-expected profit for the second quarter due to weaker oil prices and lower profit margins for refining, prompting the oil giant to cut its planned 2016 capital spending budget.

Boeing — Boeing was accused by major supplier Rockwell Collins of being delinquent in its payments, saying the jet maker is behind on tens of millions of dollars in bills due at the end of last month. Boeing issued a statement saying it was in the process of adjusting payment terms with suppliers to align with current industry norms.

Noodles & Company, Red Robin Gourmet Burgers — Jefferies downgraded a number of restaurant chain stocks to "hold" from "buy," including Noodles and Red Robin Gourmet Burgers. Jefferies cites too much capacity and a tight labor market.

Questions? Comments? Email us at